AC Immune ACIU
NASDAQ ACIU
$2.62 +0.02 (+0.77%)
At close: Sep 30, 2026 · 4:00 PM EDT

AC Immune (ACIU) Accounts Payables (2014 - 2026)

Updated

AC Immune's Accounts Payables was $1.91 million in the quarter ended Jun 30, 2026, down 41.9% from $3.3 million a year earlier but up 13.7% from the prior quarter.

Analysis

AC Immune (ACIU) Accounts Payables (2014 - 2026) Analysis & Trends

As of Dec 31, 2025, Accounts Payables at AC Immune came in at $2.49 million, down 17.4% from the prior year.

  • Accounts Payables shows a five-year compound annual growth rate of 1.4% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Accounts Payables was $3.02 million in the year ended Dec 31, 2024 (+61.6%), $1.87 million in the year ended Dec 31, 2023 (+92.0%), $973,856 in the year ended Dec 31, 2022 (-55.6%) and $2.19 million in the year ended Dec 31, 2021 (-5.9%).
  • Quarterly Accounts Payables has moved between $234,163 (the quarter ended Sep 30, 2021) and $3.3 million (the quarter ended Jun 30, 2025) over five years.
  • Compared with a year earlier, Accounts Payables has declined for three straight quarters, with growth averaging 9.2% over the last eight quarters.
  • The best year-over-year quarter for Accounts Payables over five years was the quarter ended Sep 30, 2022 (growth of 571.7%); the worst was the quarter ended Sep 30, 2021 (a decline of 78.9%).
  • Per Business Quant data, ACIU's Accounts Payables in the three quarters before the quarter ended Jun 30, 2026 was $1.68 million (quarter ended Mar 31, 2026), $2.59 million (quarter ended Dec 31, 2025) and $1.96 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 AC Immune 266.56 Mn 266.56 Mn - 1.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.91 Mn
Mar 31, 2026 1.68 Mn
Dec 31, 2025 2.59 Mn
Sep 30, 2025 1.96 Mn
Jun 30, 2025 3.30 Mn
Mar 31, 2025 2.66 Mn
Dec 31, 2024 3.03 Mn
Sep 30, 2024 1.63 Mn
Jun 30, 2024 1.59 Mn
Mar 31, 2024 3.25 Mn
Dec 31, 2023 1.89 Mn
Sep 30, 2023 1.67 Mn
Jun 30, 2023 1.50 Mn
Mar 31, 2023 1.23 Mn
Dec 31, 2022 964,322.36
Sep 30, 2022 1.57 Mn
Jun 30, 2022 349,904.74
Mar 31, 2022 542,487.00
Dec 31, 2021 2.17 Mn
Sep 30, 2021 234,162.76
API Access

AC Immune Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=ACIU&period=max&api_key=YOUR_API_KEY